Atlas Trials

Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy

Clinical trial NCT03010722 · COMPLETED

Trial details

NCT number
NCT03010722
Sponsor
Royal Marsden NHS Foundation Trust
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Colorectal Cancer
Start date
2015-01-01
Primary completion
2017-01-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.